The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids
- 1 April 2017
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 40, 105-110
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Uterine FibroidsNew England Journal of Medicine, 2015
- Selective progesterone receptor modulators: a class with multiple actions and applications in reproductive endocrinology, and gynecologyGynecological Endocrinology, 2014
- Fibroid growth and medical options for treatmentFertility and Sterility, 2014
- The immninent dawn of SPRMs in obstetrics and gynecologyMolecular and Cellular Endocrinology, 2012
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safetyFertility and Sterility, 2011
- Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysisThe Lancet, 2010
- Effects of the Progesterone Receptor Modulator VA2914 in a Continuous Low Dose on the Hypothalamic-Pituitary-Ovarian Axis and Endometrium in Normal Women: A Prospective, Randomized, Placebo-Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2007
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and EndometriosisEndocrine Reviews, 2005
- Andrology: Failure of oestrogen induced luteinizing hormone surge in women treated with mifepristone (RU 486) every day for 30 daysHuman Reproduction, 1995
- RU 486Scientific American, 1990